[1]
A. Trifan, “Effectiveness of 8- and 12-Week Treatment with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania: the AMETHYST Study”, JGLD, vol. 30, no. 1, pp. 88-93, Mar. 2021.